We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IMNM market cap is 660.99M. The company's latest EPS is USD -1.7112 and P/E is -6.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.57M | 3.83M | 1.03M | 2.36M | 2.91M |
| Operating Income | -4.63M | -94.65M | -132.3M | -40.01M | -50.52M |
| Net Income | -4.35M | -92.63M | -129.49M | -36.12M | -47.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 503k | 0 | 14.02M |
| Operating Income | -10.35M | -12.26M | -24.7M | -36.9M | -109.53M |
| Net Income | -10.44M | -17.84M | -24.71M | -37.52M | -106.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 93.16M | 148.54M | 319.75M | 296.22M | 256.9M |
| Total Liabilities | 87.09M | 28.66M | 34.18M | 42.38M | 41.99M |
| Total Equity | 6.08M | 119.88M | 285.57M | 253.84M | 214.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.06M | 44.53M | 57.93M | 24.05M | 148.54M |
| Total Liabilities | 1.8M | 3.18M | 9.74M | 7.39M | 28.66M |
| Total Equity | -35.63M | 41.35M | 48.19M | 16.65M | 119.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.89M | -7.57M | -11.17M | -34.57M | -68.73M |
| Investing | -482k | -30.48M | -37.23M | -118.92M | -94.82M |
| Financing | 60.91M | 116.41M | 219.45M | 220.14M | 220.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.6M | -12.13M | -18.23M | -28.69M | -7.57M |
| Investing | -233k | -586k | -79k | -248k | -30.48M |
| Financing | 10.77M | 49.94M | 27.77M | 32k | 116.41M |
| Market Cap | 660.99M |
| Price to Earnings Ratio | -6.16 |
| Price to Sales Ratio | 46.93 |
| Price to Cash Ratio | 6.67 |
| Price to Book Ratio | 5.49 |
| Dividend Yield | - |
| Shares Outstanding | 62.42M |
| Average Volume (1 week) | 551.07k |
| Average Volume (1 Month) | 836.46k |
| 52 Week Change | -6.70% |
| 52 Week High | 30.958 |
| 52 Week Low | 8.97 |
| Spread (Intraday) | 0.05 (0.47%) |
| Company Name | Immunome Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.immunome.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
